- Home
- REI vs PRQR Comparison
REI vs PRQR Comparison
Compare REI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REI
- PRQR
- Stock Information
- Founded
- REI 2004
- PRQR 2012
- Country
- REI United States
- PRQR Netherlands
- Employees
- REI N/A
- PRQR N/A
- Industry
- REI Oil & Gas Production
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- REI Energy
- PRQR Health Care
- Exchange
- REI Nasdaq
- PRQR Nasdaq
- Market Cap
- REI 208.6M
- PRQR 224.4M
- IPO Year
- REI N/A
- PRQR 2014
- Fundamental
- Price
- REI $1.09
- PRQR $2.45
- Analyst Decision
- REI
- PRQR Strong Buy
- Analyst Count
- REI 0
- PRQR 8
- Target Price
- REI N/A
- PRQR $8.88
- AVG Volume (30 Days)
- REI 2.5M
- PRQR 399.8K
- Earning Date
- REI 11-05-2025
- PRQR 11-06-2025
- Dividend Yield
- REI N/A
- PRQR N/A
- EPS Growth
- REI N/A
- PRQR N/A
- EPS
- REI 0.35
- PRQR N/A
- Revenue
- REI $318,900,835.00
- PRQR $20,129,184.00
- Revenue This Year
- REI N/A
- PRQR N/A
- Revenue Next Year
- REI $9.58
- PRQR N/A
- P/E Ratio
- REI $3.16
- PRQR N/A
- Revenue Growth
- REI N/A
- PRQR 8.65
- 52 Week Low
- REI $0.72
- PRQR $1.07
- 52 Week High
- REI $1.81
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- REI 56.57
- PRQR 64.34
- Support Level
- REI $1.04
- PRQR $2.08
- Resistance Level
- REI $1.18
- PRQR $2.19
- Average True Range (ATR)
- REI 0.06
- PRQR 0.13
- MACD
- REI -0.00
- PRQR 0.02
- Stochastic Oscillator
- REI 52.50
- PRQR 99.10
About REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.